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Chronic renal transplant failure (CRTF) is the predominant cause of late graft Íailure. One of the
histological features in the transplanted kidney is intimal hyperplasia. In the present thesis,
experiments are described studying vascular changes in CRTF. There sti l l  is no treatment o
prevent CRTF. In other renal diseases, ACE inhibitors are used to prevent or slow down the
progression of renal failure by normalizing proteinuria, reducing blood pressure and attenuating
fibrosis. Therefore, in the second chapter, we studied the therapeutic effects of ACE inhibit ion
on ORTF. We transplanted kidney grafts in the Fisher to Lewis allogeneic rat strain
combination. These rats were subsequently treated with either an ACE inhibitor or an AT1
receptor blocker. Both treatments were shown to be beneficial with respect to proteinuria,
hypercholesterolemia, and glomerulosclerosis. However, we found that long{erm treatment of
the allografted rats caused severe ir:t imal hyperplasia in the transplanted organ. The cells
present in the intima were of myofibroblastic origin. Other studies using ACE inhibit ion in
experimental transplantation did not f ind this severe intimal hyperplasia or reported favourable
effects of ACE inhibit ion on intimal thickness, but these studies lasted for a maximum oÍ 20124
weeks. Our data in rats in which treatment was started at a later t ime point suggested that
intimal hyperplasia starts after 20 to 24 weeks of RAS blockade. Our study suggests that long-
term absence of angiotensin l l action results in renal vascular pathology. Other studies indeed
show that growth factor production occurs not only at high levels of angiotensin l l [1 ,2,3], but
also when angiotensin l l is absent [4].
In chapter 3 we tried to identify the mechanisms underlying the ACE inhibit ion induced
intimal hyperplasia. First, to assess whether ACE inhibit ion induced vascular thickening is
allospecific, we treated Fisher to Lewis allografts and syngrafts (Lewis to Lewis and Fisher to
Fisher) with cyclosporin A and ACE inhibit ion. Second, to determine whether the effect is
specific for the allocombination Fisher to Lewis, we now also used the Lewis to Fisher allograft
combination, treated with cyclosporiu A and ACE inhibit ion. ' i  nird, to determine if the
combination cyclosporin A-ACE inhibit ion contributes to ACE inhibit ion induced intimal
hyperplasia, we also included a group of allografted rats (Fisher to Lewis) which were not
treated with cyclosporin A, but received ACE inhibit ion onlv. We foirnd that chronic treatment
with ACE inhibit ion in syngrafted or ailografted rats with a Fisher kidney graft causes severe
intimal hyperplasia, whereas the Lewis graft is protected in both combinations. Although ACE
inhibit ion induced intimal hyperplasia depends on the donor kidney, it is significantly aggravated
by allografting. The short course of cyclosporin A treatment did not contribute to ACE inhibit ion
induced intimal hyperplasia. Studies ln angiotensin knock out mice have revealed that these
mice have vascular abnormalit ies and increased vascular exDression of PDGF. ln vitro studies
have shown that smooth muscle cells of Fisher rats have an increased growth response to
PDGF compared to Lewis rats [5]. This interstrain difference may also be involved in the
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In chapter 4 we investigated strain-related differences in intrarenal ACE activity between
Fisher and Lewis rats, since Fisher rats are more vuinerable to develop renal damage^ In
aCdition, we tested whether treatment with ACE inhibition in allografted rats results in reduction
of intrarenal ACE. We found that Fisher rats have signiflcantly higher ACE activity and ACE
mRNA expression, in comparison with Lewis rats. In addition, using immunohistochemistry, we
found that the Fisher rat has a strong tubular ACE expression, whereas the Lewis rat has no
tubular ACE at all. This difference in ACE levels may have a genetic origin, similar to the ACE
polymorphism in humans. The higher intrarenal ACE activity of the Fisher rat may explain the
higher glomerular intracapillary pressures found in these rats, compared with Lewis rats [6]. In
addition, these high ACE levels may render the Fisher rat more vulnerable to interstitial fibrosis
and inflammation, since angiotensin ll is a pro-inflammatory and fibrotic agent. Treatment of the
allografted rats with ACE inhibition prevented proteinuria and glomerulosclerosis and reduced
ACE activity with 58%. These Íindings suggest that a high intrarenal ACE status predisposes to
transplantation related renal damage.
In chapter 5 we studied the presence of ischemic iniury in the renal graft of allografted rats
and the effect of ACE inhibition on ischemic injury. Down-regulation of the enzyme ecto-
ATPase in combination with up-regulation of the enzyme ecto-5'-nucleotidase is a hallmark for
ischemic damage. The untreated allografted rats revealed marked up-regulation of ecto-S'-
nucleotidase in the renal vasculature and this was further enhanced by ACE inhibit ion. This
staining pattern points to ischemic damage in the renal vasculature, the obliteration oÍ renal
arteries promotes an ischemic environment. Glomerular ecto-ATPase staining was reduced in
untreated allografts, possibly due to ischemic damage, however, ACE inhibition prevented
glomerulosclerosis and also prevented the reducfion in ecto-ATPase staining. This
renoprotective effect of ACE inhibition may depenC upon the effect ACE inhibition has on renal
interstitial oxygenation [7].
As cardiovascular disease is a major cause oÍ death following renal transplantation, in
chapter 6 the consequences oÍ renal transplantation on the extrarenal vasculature of the
recipient animal was studied in rat aortic rings. We found that NO pathways were not affected in
syngrafted and allografted rats at 34 weeks after transplantation. However, the contribution oÍ
COX-derived prostaglandins in vascular function outside the transplanted organ is strongly
diminished after allogeneic transplantation. RAS blockade íails to restore prostaglandin
function, despite major improvements oÍ the common cardiovascular isk factors in this model.
In conclusion, we Íound that ACE inhibit ion lowers blood pressure, reduces
hypercholesterolemia nd proteinuria and prevents glomerulosclerosis in the Fisher to Lewis
allograft combination. However, long term treatment oÍ the transplanted rats with ACE inhibition
causes severe renal intimal hyperplasia in Fisher kidney grafts, which was aggravated by
allografting. ACE inhibit ion prevents ischemic damage in the glomeruli, but worsens ischemic
damage in the intrarenal vessels. The altered cardiovascular prostaglandin Íunction outside the
transplanted organ in the allografted rat could not be restored by ACE inhibition.
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